Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > The only tools on here are the pumpers

<< Previous

Bullboard Posts

Next >>

Comment by SamV21on Apr 01, 2022 11:02am

55 Views

Post# 34567119

RE:RE:The only tools on here are the pumpers

So now here you are once again speaking for the company ,making false statements, when you know nothing, Fda has approved nothing , you don't work at the FDA or Tetra or Health Canada .How are those warrants doing you bought at .12 Mr. pump it all ? Comments from Guy or you don't make any money for any of us. So stop the pumping .

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing